Introduction {#S1}
============

Oxidative stress occurs throughout animal life, with many factors contributing to the induction of oxidative stress, such as birth, weaning, changes in food sources, and transportation ([@B12]; [@B3]; [@B50]; [@B24]; [@B14]). Weaning induces both acute and long-lasting changes in the intestines of piglets, including the shortening of villus height and increasing crypt depth ([@B2]), as well as reducing digestive enzyme activities ([@B39]). After weaning for 3 days, the jejunal antioxidant-related genes (Cu--Zn superoxide dismutase, Mn superoxide dismutase, glutathione peroxidase 1, and glutathione peroxidase 4) of piglets are significantly decreased ([@B50]), and cytokines' mRNA expression level \[tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), and interleukin (IL-6)\] are significantly increased; jejunal epithelial permeability are markedly raised ([@B16]). Diquat is widely used to induce oxidative stress in intestine of piglets ([@B44]; [@B51]; [@B4]). Diquat-induced oxidative stress has a negative effect on jejunal and ileal morphology ([@B44]; [@B51]), and it could increase the histopathological grading of the jejunum, ileum, and colon ([@B51]); the activities of antioxidant enzymes (superoxide dismutase, glutathione peroxidase) and the permeability of jejunal epithelium significantly decrease ([@B4]). Thus, the weaning period is the time in which piglets experience an increased prevalence of gastrointestinal dysfunctions, which in turn reduces growth performance in pigs and subsequently leads to economic loss ([@B28]).

Taurine is abundant in muscle tissue but has a low concentration in body fluids, such as serum and urine in pig ([@B18]; [@B45]), and it has varied biological and physiological functions, such as protective and inflammatory roles ([@B29]; [@B46], [@B45]). Taurine presents a high level in the small intestine ([@B19]). Several studies have shown that treatment with taurine has a protective effect on intestinal injuries owing to ischemia--reperfusion and lipopolysaccharides ([@B42]; [@B48]), which is supported by the significant decrease in histological scores and apoptosis indices after ischemia--reperfusion in rats ([@B53]). In dextran sulfate sodium-induced experimental colitis, taurine supplementation significantly alleviates diarrhea severity in C57BL/6 mice ([@B41]). In a model of potassium bromate-induced intestinal oxidative injury, taurine exerts an ameliorative effect by improving antioxidant defense and duodenum tissue integrity ([@B1]). However, some studies have shown that taurine impairs or has no beneficial effect on intestinal growth or on the mucosal structure of broiler chickens ([@B52]; [@B17]). Excessive taurine supplementation (3%) was observed to have adverse effects on diarrhea index, villus height, and crypt depth ([@B22]). These results suggest that the dose of taurine supplementation used was not suitable in these experiments and that this aspect merits further research.

Normal intestinal function depends on the founding and conservation of a mucosal barrier, which is coated by a monolayer of intestinal epithelial cells. The intestinal mucosal barrier is indispensable for preventing intestinal injury owing to microbiota or undesirable substances ([@B13]). However, the intestinal barrier is not fully developed at birth ([@B40]). The formation of tight junctions creates one of the major components of the intestinal barrier ([@B31]). Occludin was the first identified tight junction protein, whereas claudins are the main proteins that contribute to the physiological and structural paracellular barrier function ([@B10]). Researchers who have examined the intestinal barrier function mainly focus on the duodenum ([@B48]), jejunum, and ileum ([@B42]), as well as on cell lines with H~2~O~2~-induced oxidative stress ([@B44]). In spite of this, there have been a few studies on the use of taurine in piglets. [@B22] have reported the effect of taurine in the intestinal health of weaned pigs. Moreover, a few studies have collectively examined the duodenum, jejunum, and ileum to examine intestinal barrier function during oxidative stress.

Taking all of this into consideration, it is worthwhile to explore oxidative stress in the livestock industry. A previous study has found that the growth performance was negatively affected (such as reduced food intake, bodyweight, etc.) after diquat challenge ([@B51]). Taurine supplementation (0.60%) abolished the depression of pig growth performance (unpublished data). Moreover, pigs are comparable to humans in terms of gastrointestinal tract structure and function; thus, these pig nutritional programming studies can provide reference for human nutrition studies ([@B13]). In our previous study, we found that during oxidative stress, the protein expression of the taurine transporter is significantly increased, whereas it is ameliorated when taurine is added to the small intestines of piglets, and the concentration of taurine in blood is increased in a dose-dependent manner when fed diets contain different taurine content ([@B45]). However, whether taurine can alleviate the piglets' intestinal oxidative stress through the restoration of the physiological function of the intestinal mucosa is not clear. Therefore, in this study, we hypothesized that taurine supplementation could alleviate diquat-induced intestinal damages; as such, we investigated the alleviative effects of taurine on piglets with diquat-induced intestinal oxidative stress.

Materials and Methods {#S2}
=====================

Animals and Dieting {#S2.SS1}
-------------------

This study was conducted according to the Chinese Guidelines for Animal Care Welfare. Protocols were approved by the Committee on Animal Care of the Institute of Subtropical Agriculture, Chinese Academy of Sciences (ethical approval code: ISA-2017-012). Thirty-five weaned piglets were randomly allotted into five groups (*n* = 7). The control group (CON) was treated with a basic diet and intraperitoneal (ip) injection of isometric sterilized saline. The diquat group (DIQ) was treated with basic diet and ip administration of diquat; the low taurine group (LT) was treated with basic diet + 0.15% taurine and ip administration of diquat; the middle taurine group (MT) was treated with basic diet + 0.30% taurine and ip injection of diquat; and the high taurine group (HT) was treated with basic diet + 0.60% taurine and ip administration of diquat. According to a previous study, supplementing with 0.30% taurine increased the villus height, while 3% taurine supplementation reduced intestinal health of weaned piglets, such as higher diarrhea index, lower villus height, and deeper crypt depths ([@B22]). The saline or diquat treatments were conducted once at the beginning of the formal experiment. Diquat was purchased from Sigma (CAS Number 6358-62-2) and was dissolved in sterilized saline at a concentration of 9.6 mg/ml. Diquat would evoke vomit; therefore, diquat was administered by intraperitoneal injection. The injection volume was limited to 10 ml as described previously ([@B45]). The diets were isoenergetic, isonitrogenous, and were ensured to have met the nutritional requirements according to the National Research [@B6]. The content of taurine in diet was measured according to previous method ([@B45]). Feed composition is presented in [Table 1](#T1){ref-type="table"}.

###### 

Ingredient and chemical composition of the experimental diet.

  Items                                  Treatment                   
  -------------------------------------- ----------- ------- ------- -------
  **Ingredient composition (g/100 g)**                               
  Corn                                   64.15       64.23   64.38   64.61
  Soybean meal                           19.80       19.40   19.00   18.10
  Soybean protein concentrate            5.00        5.00    5.00    5.00
  Dried whey                             4.30        4.30    4.30    4.30
  Fish meal                              4.00        4.00    4.00    4.00
  Soya bean oil                          0.35        0.50    0.60    0.90
  Taurine                                0.00        0.15    0.30    0.60
  Lysine                                 0.36        0.37    0.37    0.41
  Methionine                             0.12        0.12    0.12    0.13
  Threonine                              0.09        0.10    0.10    0.11
  Tryptophan                             0.01        0.01    0.01    0.02
  CaHPO~4~                               0.00        0.00    0.00    0.00
  Limestone                              0.52        0.52    0.52    0.52
  NaCl                                   0.30        0.30    0.30    0.30
  1% Premix^a^                           1.00        1.00    1.00    1.00
  **Nutrient level (g/100 g)**                                       
  Digestible energy(MJ/kg)^b^            14.59       14.59   14.58   14.57
  Crude protein                          20.11       20.12   20.11   20.12
  SID lysine                             1.24        1.23    1.23    1.24
  SID methionine + cysteine              0.69        0.69    0.68    0.68
  SID threonine                          0.73        0.74    0.73    0.73
  SID tryptophan                         0.21        0.21    0.20    0.21
  Total calcium                          0.49        0.48    0.48    0.48
  Total phosphorus                       0.43        0.43    0.43    0.42
  Digestible phosphorus                  0.22        0.22    0.22    0.21
  Taurine^c^                             0.02        0.13    0.27    0.56
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Calculated values, other values are measured.

c

Measured values.

Sample Collection {#S2.SS2}
-----------------

After the feeding period (28 days), blood samples were collected from the overnight fasting piglets by vein puncture. To do this, pigs were electrically stunned (250 V, 0.5 A, 5--6 s) and bled by the exsanguination of the precaval vein. Blood samples were then centrifuged at 3,000 × *g* for 10 min, after which the supernatants were collected and stored at -80°C until the downstream analyses were performed. Intestinal mucosa samples were cleaned using phosphate-buffered saline (PBS) and were collected using a glass slide. All samples were placed into liquid N~2~ and stored at -80°C until further analysis.

Serum Immunoglobulin {#S2.SS3}
--------------------

Serum immunoglobulin A (IgA) (CSB-E13234p), immunoglobulin G (IgG) (CSB-E06804p), and immunoglobulin M (IgM) (CSB-E06805p) levels were determined using an ELISA kit (Cusabio, Wuhan, China). All experiments were performed according to the manufacturer's instructions. Briefly, we used a serum separator tube, and samples were allowed to clot for 2 h at room temperature before centrifugation for 15 min at 1,000 × *g*. It was recommended to dilute the serum with 2,000-fold dilution for test IgA and IgM and with 1,000-fold dilution for test IgG. This assay employs the competitive inhibition enzyme immunoassay technique. Then, we used the professional soft "Curve Expert" to make a standard curve. The concentration read from the standard curve were multiplied by the dilution factor.

Analysis of Intestinal Morphology {#S2.SS4}
---------------------------------

Small intestine samples (duodenum, jejunum, ileum; 3 cm) were prepared for histological analysis; these were collected and immediately fixed in 4% neutral buffered formalin. Afterward, the samples were seated into paraffin blocks, and three cross-sections for each sample were cut into 6-μm-thick sections and stained with H&E. Villus height and crypt depth were measured from at least 12 well-oriented crypt--villus units by upright fluorescence microscopy using a model BX51 microscope (Olympus, Tokyo, Japan), as previously described ([@B45]).

RNA Extraction and Real-Time RT-PCR {#S2.SS5}
-----------------------------------

Reverse transcription and real-time quantitative PCR (RT-qPCR) were performed as previously described ([@B8]; [@B45]). TRIzol reagent (Invitrogen-Life Technologies, CA, United States) was used for total RNA extraction. Premixed Taq^TM^ DNA Polymerase (TaKaRa, Otsu, Japan) was used for PCR analysis. RT-PCR was performed by Roche LightCycler 480 II (Roche, Basel, Switzerland). The messenger RNA (mRNA) expression levels of the target genes were determined by the 2^--ΔΔCt^ method, using the following formula: \[*ΔΔ*^Ct^ = (Ct~gene\ of\ interest~ -- Ct~β--actin~)~treated~ -- (Ct~gene\ of\ interest~ - Ct~β--actin~)~untreated~\] ([@B21]). β-Actin housekeeping gene was used as an internal control to normalize target gene transcript levels. Primers for the selected genes ([Table 2](#T2){ref-type="table"}) were designed using the Primer 5.0 software.

###### 

Characteristics of the primers used for real-time PCR analysis.

  Genes         Primer (from 5′ to 3′)      Product size (bp)   Accession no.
  ------------- --------------------------- ------------------- ----------------
  *Claudin-1*   F:CTCAATACAGGAGGGAAGCCA     91                  NM-001244539.1
                R: ATATTTAAGGACCGCCCTCTCC                       
  *Occludin*    F: TCAGGTGCACCCTCCAGATT     167                 NM-001163647.2
                R: TGTCGTTGCTGGGTGCATAA                         
  *ZO-1*        F:ACCATGTCTTGAAGCAGCCA      103                 XM-021098896.1
                R: GCCTGTCTCTCCATGTACGG                         
  β*-actin*     F:CTGCGGCATCCACGAAACT       147                 XM-021086047.1
                R: AGGGCCGTGATCTCCTTCTG                         

ZO-1, zonula occludens-1.

Western Blotting Analysis {#S2.SS6}
-------------------------

Relative protein levels for the tight junction proteins ZO-1, claudin-1, and occludin in the small intestine were determined using Western blot ([@B8]; [@B45]). Protein content of intestine samples was detected by BCA Protein Assay Kit according to the manufacturer's instructions (Beyotime, Shanghai, China). The resultant signals were obtained using the AlphaImager 2200 software (Alpha Innotech Corporation., San Leandro, CA, United States). The primary antibodies used in this experiment are ZO-1 (\#21773-1-AP) at a dilution of 1:700, claudin-1 (\#13050-1-AP) at a dilution of 1:500, and occludin (\#66378-1-Ig) at a dilution of 1:1,000, and β-actin (\#60008-1-Ig) at a dilution of 1:5,000, which were all purchased from Proteintech Group (Chicago, IL, United States).

Statistical Analysis {#S2.SS7}
--------------------

The data were analyzed using one-way analysis of variance (ANOVA) and Duncan's multiple range test (SAS 8.2). Data were expressed as mean ± SEM. Values in the same row marked with different letters are significantly different (*P* \< 0.05).

Results {#S3}
=======

Serum Immunoglobin {#S3.SS1}
------------------

The results of serum immunoglobin analysis are presented in [Figure 1](#F1){ref-type="fig"}. Compared with CON, diquat-induced oxidative stress significantly decreased the IgM level and significantly increased IgG (*P* \< 0.05). Compared with DIQ, taurine supplementation was able to restore the IgA levels with no dose effect. Compared with DIQ, IgM levels were significantly increased in MT and HT (*P* \< 0.05), whereas IgG levels were significantly decreased in MT and HT (*P* \< 0.05).

![The concentration of serum immunoglobulin in diquat-induced oxidative stress with piglets. **(A)** The effect of taurine on serum IgA in diquat-induced oxidative stress of piglets; **(B)** the effect of taurine on serum IgM in diquat-induced oxidative stress of piglets; **(C)** the effect of taurine on serum IgG in diquat-induced oxidative stress of piglets. CON, control group; DIQ, diquat-treated group; LT, piglets supplemented with 0.15% taurine and treated with diquat; MT, piglets supplemented with 0.3% taurine and treated with diquat; HT, piglets supplemented with 0.6% taurine and treated with diquat. IgA, immunoglobulin A; IgM, immunoglobulin M; IgG, immunoglobulin G. Results were expressed as mean ± SEM, *n* = 7. ^a,b,c^Mean values with dissimilar letters were significantly different (*P* \< 0.05).](fphys-11-00449-g001){#F1}

Morphology {#S3.SS2}
----------

[Figure 2](#F2){ref-type="fig"} shows intestinal HE staining results (duodenum, jejunum, and ileum) of piglets with diquat-induced oxidative stress and taurine supplementation. Our results showed that supplementation with taurine could alleviate the intestinal injury to some extent.

![Effect of taurine on intestinal morphological structure in diquat-induced oxidative stress with weaned piglets (HE, × 200). CON, control group; DIQ, diquat-treated group; LT, piglets supplemented with 0.15% taurine and treated with diquat; MT, piglets supplemented with 0.3% taurine and treated with diquat; HT, piglets supplemented with 0.6% taurine and treated with diquat.](fphys-11-00449-g002){#F2}

[Figure 3](#F3){ref-type="fig"} shows the measured values of intestinal villus height, crypt depth, and V/C ratio. Compared with CON, the villus height of the small intestine (duodenum, jejunum, and ileum) were significantly decreased in DIQ (*P* \< 0.05); furthermore, we found that 0.60% taurine supplementation (HT) could restore the villus height of the small intestine. Compared with CON, the crypt depth of duodenum was significantly increased in DIQ (*P* \< 0.05). Compared with DIQ, 0.60% taurine supplementation could effectively decrease crypt depth in the small intestine (*P* \< 0.05). Compared with CON, V/C ratio was significantly decreased in DIQ, and compared with DIQ, 0.60% taurine supplementation was found to improve V/C ratio (*P* \< 0.05).

![The small intestinal villus height and crypt depth with diquat-induced oxidative stress and taurine supplementation in piglets. **(A)** The effect of taurine on villus height of duodenum; **(B)** the effect of taurine on crypt depth of duodenum; **(C)** the effect of taurine on V/C of duodenum; **(D)** the effect of taurine on villus height of jejunum; **(E)** the effect of taurine on crypt depth of jejunum; **(F)** the effect of taurine on V/C of jejunum; **(G)** the effect of taurine on villus height of ileum; **(H)** the effect of taurine on crypt depth of ileum; **(I)** the effect of taurine on V/C of ileum. CON, control group; DIQ, diquat-treated group; LT, piglets supplemented with 0.15% taurine and treated with diquat; MT, piglets supplemented with 0.3% taurine and treated with diquat; HT, piglets supplemented with 0.6% taurine and treated with diquat. V/C, villus height/crypt depth. Results were expressed as mean ± SEM, *n* = 7. ^a,b,c,d^Mean values with dissimilar letters were significantly different (*P* \< 0.05).](fphys-11-00449-g003){#F3}

Tight Junction mRNA Expression {#S3.SS3}
------------------------------

The mRNA expression levels of *claudin-1*, *occludin*, and *ZO-1* in the intestinal mucosa (duodenum, jejunum, and ileum) are presented in [Figure 4](#F4){ref-type="fig"}. Compared with CON, the expression of *claudin-1* and *occludin* were significantly increased in DIQ in the duodenum; however, they had no difference in the taurine supplementation group (*P* \< 0.05). Compared with CON, the expression of *occludin* was significantly decreased in DIQ in the jejunum (*P* \< 0.05). Compared with DIQ, the expression of *claudin-1*, *occludin*, and *ZO-1* were significantly increased in the HT in the ileum (*P* \< 0.05).

![The small intestinal mucosa expression of tight junction-related genes in diquat-induced oxidative stress and taurine supplementation. **(A)** the effect of taurine on the messenger RNa (mRNA) expression of *claudin-1* in the duodenum; **(B)** the effect of taurine on the mRNA expression of *occludin* in the duodenum; **(C)** the effect of taurine on the mRNA expression of *ZO-1* in duodenum; **(D)** the effect of taurine on the mRNA expression of *claudin-1* in jejunum; **(E)** the effect of taurine on the mRNA expression of *occludin* in jejunum; **(F)** the effect of taurine on the mRNA expression of *ZO-1* in jejunum; **(G)** the effect of taurine on the mRNA expression of *claudin-1* in ileum; **(H)** the effect of taurine on the mRNA expression of *occludin* in ileum; **(I)** the effect of taurine on the mRNA expression of *ZO-1* in ileum. CON, control group; DIQ, diquat-treated group; LT, piglets supplemented with 0.15% taurine and treated with diquat; MT, piglets supplemented with 0.3% taurine and treated with diquat; HT, piglets supplemented with 0.6% taurine and treated with diquat. Results were expressed as mean ± SEM, *n* = 7. ^a,b^Mean values with dissimilar letters were significantly different (*P* \< 0.05).](fphys-11-00449-g004){#F4}

Tight Junction Protein Expression {#S3.SS4}
---------------------------------

The protein expression levels of claudin-1, occludin, and ZO-1 in the intestinal mucosa (duodenum, jejunum, and ileum) are presented in [Figure 5](#F5){ref-type="fig"}. Compared with CON, the expression of claudin-1 was significantly upregulated in DIQ in the intestine (duodenum, jejunum, and ileum) (*P* \< 0.05). Furthermore, compared with DIQ, taurine supplementation significantly downregulated the expression of claudin-1 in the duodenum, and jejunum (*P* \< 0.05). Compared with CON, the expression of occludin and ZO-1 were significantly downregulated in DIQ in the intestine (duodenum, jejunum, and ileum) (*P* \< 0.05). Compared with DIQ, taurine supplementation could significantly upregulate the expression of occludin in the intestine (duodenum, jejunum, and ileum), with the exception of LT in the jejunum (*P* \< 0.05). Lastly, taurine supplementation was observed to elevate the ZO-1 expression in the intestine; however, the data were not significantly different (*P* \> 0.05).

![The small intestinal mucosa expression of tight junction-related proteins in diquat-induced oxidative stress and taurine supplementation. **(A)** The effect of taurine on the protein expression of claudin-1 in duodenum; **(B)** the effect of taurine on the protein expression of occludin in duodenum; **(C)** the effect of taurine on the protein expression of ZO-1 in duodenum; **(D)** the effect of taurine on the protein expression of claudin-1 in jejunum; **(E)** the effect of taurine on the protein expression of occludin in jejunum; **(F)** the effect of taurine on the protein expression of ZO-1 in jejunum; **(G)** the effect of taurine on the protein expression of claudin-1 in ileum; **(H)** the effect of taurine on the protein expression of occludin in ileum; **(I)** the effect of taurine on the protein expression of ZO-1 in ileum. CON, control group; DIQ, diquat-treated group; LT, piglets supplemented with 0.15% taurine and treated with diquat once time; MT, piglets supplemented with 0.3% taurine and treated with diquat once time; HT, piglets supplemented with 0.6% taurine and treated with diquat once time. Results were expressed as mean ± SEM, *n* = 7. ^a,b,c^Mean values with dissimilar letters were significantly different (*P* \< 0.05).](fphys-11-00449-g005){#F5}

Discussion {#S4}
==========

Weaning piglets frequently suffer from oxidative stress, which impairs growth and intestinal development ([@B16]; [@B50]; [@B4]). Taurine is known to exert a protective effect after damage ([@B46]). Our results indicated that oxidative stress triggers an aberrant immune response and has negative effects on intestinal morphology and tight junction barriers. Supplementation with taurine is an effective therapy for recovering, maintaining, or enhancing barrier function in diquat-induced intestinal injury.

Diquat is a toxin that affects cell survival and immune response ([@B7]; [@B34]), whereas immunoglobulins play vital roles in mediating immune responses. Serum immunoglobulins include IgA, IgM, and IgG. The B and T cells were exposed to antigen and eventually swallowed and thus delivered to lymphoid cells; the B cells mature into plasma cells and secrete immunoglobulins ([@B5]). The immunoglobulin (IgA, IgG, and IgM) levels of the piglets were measured from the serum. IgG is the major serum immunoglobulin involved in mediating a protective inflammatory response ([@B20]); oxidative stress might play a role in the elevation of serum IgG ([@B33]). IgA mediates a variety of protective functions and has both anti- and proinflammatory effects ([@B35]). Natural IgM has a primary function of protecting against a range of bacterial and fungal infections ([@B9]). Adult male workers exposed to insecticides have lower levels of IgG and IgM and higher levels of cytokines ([@B30]), which is consistent with our results. Immunoglobulin production is regulated by the nuclear factor kappa B (NF-κB) signaling pathway; it is concluded that oxidative-stress-induced activation of NF-κB signal pathway plays a possible role in the increase in serum immunoglobulin content ([@B33]). It is suggested that oxidative stress alters the immune response, whereas taurine reverses these immunological abnormalities.

Physical barriers serve as the first line of defense against pathogenic agents in the external environment of the intestine ([@B38]). Following infection with *Escherichia coli*, cytokine expression of IL-1β, IL-6, TNF-α, and IL-10 in the intestinal mucosa significantly increases ([@B11]), resulting in piglets having greater villous atrophy and intestinal morphology disruption ([@B49]). Weaning is related to villus atrophy and crypt hyperplasia ([@B32]), and it is known that the small intestine crypt depth is increased starting from 3 to 7 days postweaning ([@B15]). On the other hand, dietary taurine has various effects on intestinal health. A study in chickens has shown that, when supplemented with 0.5 g/kg of taurine, the jejunum and ileum villi have impaired development and the relative height of the intestinal mucosa decreases ([@B52]). Dietary supplementation of 0.3% taurine increases villus height, whereas 3% taurine increases diarrhea index and crypt depth and reduces villus height over that of the control ([@B22]). Thus, this study suggests that an appropriate dosage of taurine supplementation can benefit intestinal health. Supplementation with 60 mg/kg BW taurine significantly increased taurine concentration in the intestinal fluids of chickens ([@B48]). Diquat significantly increases the content of reactive oxygen species, which could activate the mitophagy and proapoptotic-related signal pathway during intestinal injury ([@B54]; [@B4]). In our study, we observed that oxidative stress impaired the development of the small intestinal morphology, shortened the villus height, decreased the ratio of V/C, and caused a negative effect on the crypt depth in the duodenum. Interestingly, we found that supplementation with 0.60% taurine increases villus height in the jejunum and ileum. Our results are consistent with those of a previous study that compared taurine-treated rats with ischemia--reperfusion animals, in which taurine caused a significant increase in villus height in the jejunum and ileum ([@B42]). Our data suggested that taurine potentially has a positive effect on intestinal damages induced by diquat.

Tight junctions form a cytoplasmic surface barrier between epithelial cells, play a central role in separating tissue compartments, and function in maintaining cellular polarity ([@B47]). In the animal model of diquat-induced oxidative stress, the concentration of TNF-α and IL-6 are significantly increased ([@B23]; [@B51]), which was consistent with our previous results (unpublished data). Oxidative stress is a chronic inflammation, and it makes the intestine more susceptible to pathogens ([@B43]). Intestinal epithelial cells promote the appropriate immune response against enteric pathogens and modulate immune response at the intestinal barrier and promote the maintenance of intestinal orchestration ([@B37]). Cytokines modulate tight junction protein expression in a protein-specific manner. Researchers have shown that TNF-α causes an increase in intestinal epithelial tight junction permeability ([@B26]; [@B25]). TNF-α induces a downregulation of claudin-1, occludin, and ZO-1 protein expression in Caco-2 cells ([@B27]). Proinflammatory cytokine IL-1β does not change ZO-1 protein expression but instead induces a progressive downregulation of occludin protein expression and an upregulation in claudin-1 protein expression in Caco-2 monolayers ([@B25]). In this study, we found that the protein expression of claudin-1 was significantly increased in DIQ in the small intestine, while the mRNA expression level of *claudin-1* was increased in the duodenum. Whether this phenomenon was induced by inflammatory cytokines still requires further investigation. Interestingly, our results showed that taurine supplementation downregulated claudin-1 protein expression in the duodenum and jejunum, low-dose taurine (0.15%) down-regulated claudin-1 protein expression, while middle- (0.30%) and high-dose (0.60%) taurine had no effect on claudin-1 protein expression in the ileum. Heat stress was found to increase occludin protein expression but had no effect on claudin-1 protein expression in the ileum of growing pigs ([@B36]). Our results showed that oxidative stress had negative effects on occludin and ZO-1 protein expression in the small intestine, which is consistent with the results of a previous study ([@B4]). Furthermore, we found that the mRNA expression level of *occludin* increased, which may be related to a compensatory effect. Taurine supplementation could restore occludin and ZO-1 protein expression in the duodenum and ileum, and this did not exhibit dose dependence. However, a low dose (0.15%) of taurine had no effect on occludin and ZO-1 protein expression in the jejunum, which is consistent with jejunal occludin mRNA expression results. Lastly, the negative effect exerted on the intestinal tight barrier by oxidative stress was ameliorated by taurine.

Under oxidative stress condition, the content of taurine decreases in urine ([@B45]), suggesting that the reabsorption of taurine is improved. Lipopolysaccharide-induced inflammation has no effect on the concentration of taurine in serum and intestinal fluids ([@B48]; [@B45]). However, the transportation of taurine is enhanced in the intestine. Cysteine dioxygenase (CDO) and cysteinesulfinate decarboxylase (CSD) are the two limited enzymes in taurine biosynthesis pathway of the liver, and its protein expression level is changed in a contrary way ([@B46], [@B45]). Taking together, these results indicated that oxidative stress could lead to taurine redistribution in tissues and fluids. The synthesis of taurine was also changed in the liver.

Conclusion {#S5}
==========

In conclusion, taurine could alleviate intestinal injury through the restoration of the intestinal morphology and tight junction barrier, with 0.60% taurine supplementation being a suitable dose. Our study provided a nutritional strategy for intestinal health. Further study is warranted to elucidate the intestinal permeability, inflammation, and immune responses that contribute to the intestinal pathologies that resulted from oxidative stress.
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:   immunoglobulin A

IgG

:   immunoglobulin G

IgM

:   immunoglobulin M

V/C

:   villus height/crypt depth.
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